Trial · NCT03263091
Participant flow72
How many started, completed or left each group, period by period.
41 to 60 of 72
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| OL High-EPO Component | COMPLETED | DB Component: Roxadustat | 0 | |
| OL High-EPO Component | COMPLETED | DB Component: Placebo | 0 | |
| OL High-EPO Component | NOT COMPLETED | OL Component (Cohort 1): Roxadustat 1.5 mg/kg | 0 | |
| OL High-EPO Component | NOT COMPLETED | OL Component (Cohort 2): Roxadustat 2.0 mg/kg | 0 | |
| OL High-EPO Component | NOT COMPLETED | OL Component (Cohort 3): Roxadustat 2.5 mg/kg | 0 | |
| OL High-EPO Component | NOT COMPLETED | OL High-EPO Component: Roxadustat 2.5 mg/kg | 10 | |
| OL High-EPO Component | NOT COMPLETED | DB Component: Roxadustat | 0 | |
| OL High-EPO Component | NOT COMPLETED | DB Component: Placebo | 0 | |
| DB Component | STARTED | OL Component (Cohort 1): Roxadustat 1.5 mg/kg | 0 | |
| DB Component | STARTED | OL Component (Cohort 2): Roxadustat 2.0 mg/kg | 0 | |
| DB Component | STARTED | OL Component (Cohort 3): Roxadustat 2.5 mg/kg | 0 | |
| DB Component | STARTED | OL High-EPO Component: Roxadustat 2.5 mg/kg | 0 | |
| DB Component | STARTED | DB Component: Roxadustat | 82 | |
| DB Component | STARTED | DB Component: Placebo | 58 | |
| DB Component | Received at Least 1 Dose of Study Drug | OL Component (Cohort 1): Roxadustat 1.5 mg/kg | 0 | |
| DB Component | Received at Least 1 Dose of Study Drug | OL Component (Cohort 2): Roxadustat 2.0 mg/kg | 0 | |
| DB Component | Received at Least 1 Dose of Study Drug | OL Component (Cohort 3): Roxadustat 2.5 mg/kg | 0 | |
| DB Component | Received at Least 1 Dose of Study Drug | OL High-EPO Component: Roxadustat 2.5 mg/kg | 0 | |
| DB Component | Received at Least 1 Dose of Study Drug | DB Component: Roxadustat | 82 | |
| DB Component | Received at Least 1 Dose of Study Drug | DB Component: Placebo | 58 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03263091/flow?page=3